Norepinephrine and β2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo

Pharmacological Reviews

Volumn 53, Issue 4, 2001, Pages 487-525

  Kohm, A P ^a   Sanders, V M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; NORADRENALIN;

ANIMAL CELL; ANTIBODY PRODUCTION; AUTONOMIC NERVOUS SYSTEM; B LYMPHOCYTE ACTIVATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CYTOKINE RELEASE; DRUG EFFECT; HOST RESISTANCE; LYMPHOCYTE FUNCTION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVIEW; SHEEP; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; HUMANS; LYMPHOCYTE ACTIVATION; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0035210457     PISSN: 00316997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (327)

1. 3H]-noradrenaline from isolated human atrial appendages
2. Ontogeny and senescence of noradrenergic innervation of the rodent thymus and spleen
3. Noradrenergic sympathetic innervation of the spleen. III. Development of innervation in the rat spleen
4. Behaviorally conditioned immunosuppression
5. Interactions between the brain and the immune system
6. Interleukin-1 increases norepinephrine turnover in the spleen and lung in rats
7. Dopamine beta-hydroxylase deficiency impairs cellular immunity
8. Prostaglandin E2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2R alpha gene expression at multiple levels
9. Thymic factor in human sera demonstrable by a cyclic AMP assay
10. Prostaglandin synthesis in human T cells: Its partial inhibition by lectins and anti-CD3 antibodies as a possible step in T cell activation
11. Differences in cyclic AMP changes after stimulation by prostaglandins and isoproterenol in lymphocyte subpopulations
12. Signal transduction by interleukin-12 and interleukin-2. A comparison and contrast
13. Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset-specific modulation of beta 2-adrenergic receptors
14. Cultured sympathetic neurons express functional interleukin-1 receptors
15. Prostaglandin inhibition of T-cell proliferation is mediated at two levels
16. Peptides and the blood-brain barrier: Lipophilicity as a predictor of permeability
17. Permeability of the blood-brain barrier to neuropeptides: The case for penetration
18. Saturable transport of peptides across the blood-brain barrier
19. Blood to brain transport of interleukin links the immune and central nervous systems
20. Human interleukin (IL)-1-alpha, murine IL-1-alpha and murine IL-1-beta are transported from blood to brain in the mouse by a shared saturable mechanism
21. Lymphocyte-mediated regulation of neurotransmitter gene expression in rat sympathetic ganglion
22. Sympathetic and afferent neurons projecting in the splenic nerve of the cat
23. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells
24. Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: Lack of correlation between inhibition of T cell proliferation and cAMP accumulation
25. Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: Relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation
26. A longitudinal study of age-related loss of noradrenergic nerves and lymphoid cells in the rat spleen
27. Innervation of lymphoid organs and implications in development, aging, and autoimmunity
28. Catecholamine induced leukocytosis: Early observations, current research, and future directions
29. The immune response evokes changes in brain noradrenergic neurons
30. Immunoregulation mediated by the sympathetic nervous system
31. Cutting edge: Clonally restricted production of the neurotrophins brain- derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors
32. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
33. Catechol-O-methyltransferase activity and aminergic binding sites distribution in human peripheral blood lymphocyte subpopulations
34. Beta-adrenergic receptors in lymphocyte subpopulations
35. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes
36. Effects of human recombinant interleukins on stimulation-evoked noradrenaline overflow from the rat perfused spleen
37. B-cell responses in autoimmune diseases
38. Beta-adrenoceptor-mediated inhibition of IFN-gamma, IL-3, and GM-CSF mRNA accumulation in activated human T lymphocytes is solely mediated by the beta2-adrenoceptor subtype
39. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway
40. Adenyl cyclase in human leukocytes: Evidence for activation by separate beta adrenergic and prostaglandin receptors
41. Subtype-specific regulation of the beta-adrenergic receptors
42. Cyclic AMP and immune responses. II. Phosphodiesterase inhibitors as potentiators of polynucleotide effects on antibody formation
43. Cytokine regulation of neuronal survival
44. A theory of self-nonself discrimination
45. Application of steady state kinetics to the estimation of synthesis rate and turnover times of tissue catecholamines
46. Divergent regulation of beta 2-adrenoceptors and adenylate cyclase in the Cycmouse T lymphoma cell line TL2-9
47. International Union of Pharmacology nomenclature of adrenoceptors
48. Splenic and renal sympathetic responses to stimulation of splenic receptors in cats
49. Immune function in aged mice. IV. Loss of T cell and B cell function in thymus-dependent antibody responses
50. The innervation of the bone marrow in laboratory animals
51. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells
52. Catecholamines decrease lymphocyte adhesion to cytokine-activated endothelial cells
53. Neurotransmitter-lymphocyte interactions: Dual receptor modulation of lymphocyte proliferation and cAMP production
54. Catecholamine modulation of lymphocyte homing to lymphoid tissues
55. Down-regulation of beta-adrenergic receptors induced by mitogen activation of intracellular signaling events in lymphocytes
56. Protein phosphorylation in human peripheral blood lymphocytes. Subcellular distribution and partial characterization of adenosine 3′:5′-cyclic monophosphate-dependent protein kinase
57. Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis
58. Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis
59. Experimental methyl mercury neurotoxicity: In vivo and in vitro perturbation of brain cell-free synthesis
60. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation
61. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: Inhibition of interleukin 2 production and down-regulation of transferrin receptor expression
62. Adenosine 3′,5′-cyclic monophosphate modulates the mitogenic responses of murine B lymphocytes
63. Conditioned suppression of a thymus-independent antibody response
64. cAMP up-regulates cell surface expression of lymphocyte CXCR4: Implications for chemotaxis and HIV-1 infection
65. The beta-adrenoceptor of the human lymphocyte and human lung parenchyma
66. Inhibition of lymphocyte activation by catecholamines: Evidence for a non-classical mechanism of catecholamine action
67. Regulation of the in vitro anamnestic antibody response by cyclic AMP. II. Antigen-dependent enhancement by exogenous prostaglandins of the E series
68. Role of cyclic AMP in the modulation of IgE production by the beta-2-adrenoceptor agonist, fenoterol
69. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection
70. Beta-adrenoceptor distribution in murine lymphoid cell lines
71. Distribution of tumor necrosis factor receptor messenger RNA in normal and herpes simplex virus infected trigeminal ganglia in the mouse
72. Localization of th-cell subsets in inflammation: Differential thresholds for extravasation of Th1 and Th2 cells
73. Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A
74. Hormone receptors on cloned T lymphocytes. Increased responsiveness to histamine, prostaglandins, and beta-adrenergic agents as a late stage event in T cell activation
75. A homing selection hypothesis for T-cell trafficking
76. Regulation of G -protein-coupled receptor kinase subtypes in activated T lymphocytes. Selective increase of beta-adrenergic receptor kinase 1 and 2
77. Immunoregulation mediated by the sympathetic nervous system, II
78. Human IgE-binding factors
79. No change in plasma corticosterone and splenic norepinephrine during humoral and cellular immune responses to sheep erythrocytes in C3H mice
80. Heparin pretreatment suppresses norepinephrine concentrations in dogs in endotoxic shock
81. The antagonistic action of cyclic GMP and cyclic AMP on proliferation of B and T lymphocytes
82. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist
83. Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin
84. Age-dependent changes of B cell reactivity and T cell-T cell interaction in the in vitro antibody response
85. Endotoxin-induced activation of cerebral catecholamine and serotonin metabolism: Comparison with interleukin-1
86. Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells
87. Regulation of beta-adrenoceptor signaling in cardiac function and disease
88. Modulatory effects of glucocorticoids and catecholamines on human interleukin- 12 and interleukin-10 production: Clinical implications
89. Presynaptic modulation of release of noradrenaline from the sympathetic nerve terminals in the rat spleen
90. Splenic primary sensory afferents in the guinea pig demonstrated with anterogradely transported wheat-germ agglutinin conjugated to horseradish peroxidase
91. Molecular characterization of the human beta 3-adrenergic receptor
92. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons
93. Effects of adrenergic alpha- and beta-receptor stimulation on the release of lymphocytes and granulocytes from the spleen
94. Behaviorally conditioned immunosuppression using cyclosporine A: Central nervous system reduces IL-2 production via splenic innervation
95. Beta-adrenergic receptor-mediated suppression of interleukin 2 receptors in human lymphocytes
96. Noradrenergic sympathetic innervation of the spleen. I. Nerve fibers associate with lymphocytes and macrophages in specific compartments of the splenic white pulp
97. Noradrenergic and peptidergic innervation of secondary lymphoid organs: Role in experimental rheumatoid arthritis
98. Noradrenergic and peptidergic innervation of lymphoid tissue
99. Decreased sympathetic innervation of spleen in aged Fischer 344 rats
100. Noradrenergic sympathetic innervation of lymphoid organs
101. Noradrenergic sympathetic innervation of the spleen. II. Tyrosine hydroxylase (TH)-positive nerve terminals form synaptic-like contacts on lymphocytes in the splenic white pulp
102. Catecholaminergic innervation of the spleen: Are lymphocytes targets of noradrenergic nerves?
103. Effect of indomethacin on the blood pressure and plasma catecholamine responses to acute endotoxaemia
104. Interleukin 4 activates human B lymphocytes via transient inositol lipid hydrolysis and delayed cyclic adenosine monophosphate generation
105. Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated
106. Interleukin-1 beta and tumor necrosis factor-alpha inhibit the release of [3H]-noradrenaline from mice isolated atria
107. Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
108. Cytokine regulation of substance P expression in sympathetic neurons
109. Cloning of the cDNA for the human beta 1-adrenergic receptor
110. Beta-adrenergic receptor on murine lymphocytes: Density varies with cell maturity and lymphocyte subtype and is decreased after antigen administration
111. Norepinephrine and serotonin content of the murine spleen: Its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro
112. The effects of beta adrenergic blockade on the responses of leucocyte counts to intravenous epinephrine in man
113. The effect of adrenaline, noradrenaline, isoprenaline and salbutamol on the resting levels of white blood cells in man
114. Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia
115. Evidence implicating utilization of different T cell receptor-associated signaling pathways by Th-1 and Th-2 clones
116. Heterogeneity of lymphocyte subpopulations to pharmacologic stimulation. I. Lymphocyte responsiveness to beta adrenergic agents
117. Subdiaphragmatic vagotomy suppresses endotoxin-induced activation of hypothalamic corticotropin-releasing hormone neurons and ACTH secretion
118. cAMP is an essential signal in the induction of antibody production by B cells but inhibits helper function of T cells
119. Interleukin-1 stimulation of astroglial proliferation after brain injury
120. Influence of chronic inflammation on the level of mRNA for acute-phase reactants in the mouse liver
121. Metabolism of norepinephrine in the central nervous system
122. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: A possible mechanism for immune-to-brain communication
123. IL-2-induced cellular events
124. Glimpses into the balance between immunity and self-tolerance
125. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell
126. IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a
127. Density and agonist-promoted high and low affinity states of the beta-adrenoceptor on human B- and T-cells
128. Apoptotic signaling through the beta-adrenergic receptor. A new Gs effector pathway
129. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse
130. Effects of 6-hydroxydopamine upon primary and secondary thymus dependent immune responses
131. An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia
132. Substance P gene expression is regulated by interleukin-1 in cultured sympathetic ganglia
133. Presynaptic receptors involved in the modulation of release of noradrenaline from the sympathetic nerve terminals of the rat thymus
134. Human T lymphocyte cAMP-dependent protein kinase: Subcellular distributions and activity ranges of type I and type II isozymes
135. Interleukin-2 enhances chick and rat sympathetic, but not sensory, neurite outgrowth
136. Turning off the signal: Desensitization of β-adrenergic receptor function
137. Effect of lethal doses of bacterial endotoxin (E. coli) on sympathetic neurohormones in the rabbit
138. Adrenergic receptor signal transduction and regulation
139. Splenic afferents and some of their reflex responses
140. Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production
141. The requirement for high intracellular cyclic adenosine monophosphate concentrations distinguishes two pathways of B cell activation induced with lymphokines and antibody to immunoglobulin
142. Effects of beta2 adrenoceptor agonists on T-cell subpopulations
143. Cyclic AMP has the ability to influence multiple events during B cell stimulation
144. Lymphocyte migration across high endothelium is associated with increases in alpha 4 beta 1 integrin (VLA-4) affinity
145. 'Crosstalk': A pivotal role for protein kinase C in modulating relationships between signal transduction pathways
146. Differential regulation of T helper phenotype by interleukins 4 and 10 in an αβ T cell receptor transgenic system
147. Enhancement of splenic sympathetic nerve activity induced by central administration of interleukin-1-beta in rats
148. Structure and mechanism of the G protein-coupled receptor kinases
149. Cyclic AMP and immune responses. I. Influence of poly A:U and cAMP on antibody formation in vitro
150. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12
151. CD86 (B7-2) on human B cells: A functional role in proliferation and selective differentiation into IgE- and IgG4-producing cells
152. Effects of beta-adrenergic agents on the murine lymphocyte response to mitogen stimulation
153. cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1
154. Conditioned medium from activated splenocytes increases substance P in sympathetic ganglia
155. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer
156. Suppressed immune response to T-cell dependent antigen in chemically sympathectomized mice
157. Suppression of the primary immune response by chemical sympathectomy
158. Stimulation of the B cell receptor, CD86 (B7-2) and the beta-2-adrenergic receptor intrinsically modulates the level of IgG1 produced per B cell
159. Modulation of the beta-adrenergic receptor-coupled adenylate cyclase by chemical inducers of differentiation: Effects on beta receptors and the inhibitory regulatory protein Gi
160. Phorbol ester induces desensitization of adenylate cyclase and phosphorylation of the beta-adrenergic receptor in turkey erythrocytes
161. Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytes
162. Regulation of antibody response in vitro. X. Biphasic effect of cyclic AMP on the secondary anti-hapten antibody response to anti-immunoglobulin and enhancing soluble factor
163. Biphasic effect of cyclic AMP on IgG production and on the changes of non-histone nuclear proteins induced with anti-immunoglobulin and enhancing soluble factor
164. Fever: Role of pyrogens and cryogens
165. Adrenergic receptors as models for G protein-coupled receptors
166. Cyclic AMP is an essential factor in immune responses
167. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo
168. Norepinephrine: A messenger from the brain to the immune system
169. Activation of antigen-specific CD4+ Th2 cells in vivo increases norepinephrine release in the spleen and bone marrow
170. Age-related changes of beta-adrenoceptors in aging inbred mice
171. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: Impact on interleukin-2 receptor signaling pathway
172. Beta-adrenoceptor density and resolution of high and low affinity state on B- and T-cells in asthmatic and non-asthmatic children
173. Pharmacological actions of 6-hydroxydopamine
174. Opposite effects of the catecholamines dopamine and norepinephrine on murine polyclonal B-cell activation
175. Cyclic AMP directly inhibits IL-2 receptor expression in human T cells: Expression of both p55 and p75 subunits is affected
176. Different numbers of beta-receptors in human lymphocyte subpopulations
177. Alterations in cytokine and antibody production following chemical sympathectomy in two strains of mice
178. cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction
179. A new analysis of allogeneic interactions
180. Syk tyrosine kinase and B cell antigen receptor (BCR) immunoglobulin-alpha subunit determine BCR-mediated major histocompatibility complex class II-restricted antigen presentation
181. Mechanisms of beta-adrenergic receptor desensitization and resensitization
182. Differential up-regulation of B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen
183. Expression and functional significance of an additional ligand for CTLA-4
184. CD28/B7 system of T cell costimulation
185. Second symposium on catecholamines. Modification of sympathetic function. Immunosympatheetomy
186. 1/S phase
187. Differential regulation of mouse B-cell activation by beta-adrenoceptor stimulation depending on type of mitogens
188. Regulation of B-cell commitment to plasma cells or to memory B cells
189. Involvement of peripheral and central catecholamine systems in neural-immune interactions
190. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis
191. The detection of beta-adrenoceptors on murine lymphocytes
192. Co-release of neuropeptide Y and noradrenaline from pig spleen in vivo: Importance of subcellular storage, nerve impulse frequency and pattern, feedback regulation and resupply by axonal transport
193. Cholera toxin acts synergistically with IL-4 to promote IgG1 switch differentiation
194. Strain-specific enhancement of splenic T cell mitogenesis and macrophage phagocytosis following peripheral axetomy
195. Activation and selectivity of splenic sympathetic nerve electrical activity response to bacterial endotoxin
196. Peripheral endotoxin increases splenic sympathetic nerve activity via central prostaglandin synthesis
197. Experimental basis for neural-immune interactions
198. Sympathetic nervous system-immune system interactions in young and old Fischer 344 rats
199. Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and in vitro following chemical sympathectomy
200. Sympathetic nervous system modulation of the immune system. III. Alterations in T and B cell proliferation and differentiation in vitro following chemical sympathectomy
201. The role of the vagus nerve in cytokine-to-brain communication
202. Properties of adenylate cyclase of lymphoid cells
203. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas
204. Effects of dibutyrylcyclic AMP on the in vitro primary response of mouse spleen cells to sheep erythrocytes
205. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1)
206. Sympathetic neurons can produce and respond to interleukin 6
207. Expression ofinterleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: Modulation by tumor necrosis factor alpha (TNF-alpha)
208. A functional role for interleukin (IL)-4-driven cyclic AMP accumulation in human B lymphoeytes
209. Signal transduction through the cAMP-dependent protein kinase
210. Hemolytic plaque formation by leukocytes in vitro: Control by vasoactive amines
211. 3H] dihydroalprenolol binding to intact and broken cell preparations of human peripheral blood lymphocytes
212. Binding of alpha-adrenergic receptors stimulates the anti-mycobacterial activity of murine peritoneal macrophages
213. Beta-adrenergic receptors on splenic lymphocytes from axotomized mice
214. Sympathetic ablation alters lymphocyte membrane properties
215. The sympathetic nervous system modulates antibody response to thymus-independent antigens
216. Leukocyte adhesion molecule expression and T cell naive/memory status following isoproterenol infusion
217. Delineation of the mechanism of inhibition of human T cell activation by PGE2
218. Signalling of Bruton's tyrosine kinase, Btk
219. Differential effects of cyclic AMP on the in vitro induction of antibody synthesis
220. Up-regulation of lymphocyte beta-adrenergic receptor in Down's syndrome: A biological marker of a neuroimmune deficit
221. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: Role of cAMP in T cell proliferation
222. Pharmacological characteristics of beta-adrenoceptor binding sites in intact and sympathectomized rat spleen
223. Innervation of the spleen in the rat: Evidence for absence of afferent innervation
224. Roles of G protein subunits in transmembrane signalling
225. 3H]NE in the rat heart
226. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A
227. Differences in effect of isoproterenol stimulation on levels of cyclic AMP in human B and T lymphocytes
228. The effects of interleukin-1 beta on the activity of adrenal, splenic and renal sympathetic nerves in the rat
229. cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells
230. Macrophage inflammatory protein-2: Chromosomal regulation in rat small intestinal epithelial cells
231. Differences in beta-adrenergic receptor density and adenylate cyclase activity between normal and leukaemic leukocytes
232. Prostaglandin E2 and other cyclic AMP elevating agents inhibit interleukin 2 gene transcription by counteracting calcineurin-dependent pathways
233. Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12
234. Contribution of depressed reuptake to the depletion of norepinephrine from rat heart and spleen during endotoxin shock
235. Cardiac and splenic norepinephrine turnovers in endotoxic rats
236. Actin polymerization and pseudopod reorganization accompany anti-CD3-induced growth arrest in Jurkat T cells
237. Cyclic AMP-mediated modulation of immunoglobulin production in B cells by prostaglandin E1
238. Functional interaction between beta2-adrenoceptor agonists and interleukin-4 in the regulation of CD23 expression and release and IgE production in human
239. Model systems for studies of leukocyte migration across the blood-brain barrier
240. Comparison of saturable transport and extracellular pathways in the passage of interleukin-1-alpha across the blood-brain barrier
241. Beta-adrenoceptors display different efficiency on lymphocyte subpopulations
242. Distribution of beta-adrenergie receptors on human lymphocyte subpopulations
243. Effects of endotoxin on monoamine metabolism in the rat
244. The development of competence in resting B cells: The induction of cyclic AMP and ornithine decarboxylase activity after direct contact between B and T helper cells
245. Changes in beta-adrenergic receptor distribution on immunocytes during differentiation: An analysis of T cells and macrophages
246. Activated Th1 and Th2 cells differentially express the beta-2-adrenergic receptor: A mechanism for selective modulation of Th1 cell cytokine production
247. Cytokine production by naive and primary effector CD4(+) T cells exposed to norepinephrine
248. Prostaglandin E inhibits the production of human interleukin 2
249. Innervation of the periarteriolar lymphatic sheath of the spleen
250. Inhibition of B cell proliferation with anti-CD19 monoclonal antibodies: Anti-CD19 antibodies do not interfere with early signaling events triggered by anti-IgM or interleukin 4
251. Prostaglandin E2 and the increase of intracellular cAMP inhibit the expression of interleukin 2 receptors in human T cells
252. Variable stimulation of adenylate cyclase activity by vasoactive intestinal like peptides and beta-adrenergic agonists in murine T cell lymphomas of immature, helper, and cytotoxic types
253. Cyclic AMP and the function of eukaryotic cells: An introduction
254. Norepinephrine stimulates lymphoid cell mobilization from the perfused rat spleen via beta-adrenergic receptors
255. Behaviorally conditioned immunosuppression: Replication of a recent study
256. Prostaglandin E2 promotes B lymphocyte Ig isotype switching to IgE
257. Prostaglandin E2 promotes IL-4-induced IgE and IgG1 synthesis
258. Studies on hemorrhagic and endotoxin shock in relation to vasomotor changes and endogenous circulating epinephrine, norepinephrine and serotonin
259. Cytokines and their receptors in the central nervous system: Physiology, pharmacology, and pathology
260. Synergism between interleukins 1 beta and 6 on noradrenergic nerves in rat myenteric plexus
261. Differential expression of the beta-2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help
262. A single antigen-specific B cell can conjugate to either a type 1 or a type 2 helper T cell
263. Beta-adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro
264. Kinetics of the enhancing effect produced by norepinephrine and terbutaline on the murine primary antibody response in vitro
265. Norepinephrine and the antibody response
266. Role of alpha adrenoceptor activation in modulating the murine primary antibody response in vitro
267. Beta-2-adrenoceptor stimulation increases the number of antigen-specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size
268. Characterization of the physical interaction between antigen-specific B and T cells
269. Regulation of the in vitro anamnestic antibody response by cyclic AMP. III. Cholera enterotoxin induces lymph node cells to release soluble factor(s) which enhance(s) antibody synthesis by anti-gentreated lymph node cells
270. Selective facilitation of putative corticotropin releasing factor-secreting neurones by interleukin-1
271. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
272. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat
273. Tumor necrosis factor facilitates regeneration of injured central nervous system axons
274. A cell culture model for T lymphocyte clonal anergy
275. Theophylline and the immune response: In vitro and in vivo effects
276. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon-gamma production and diminishes interleukin 4 inhibition of such priming
277. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice
278. Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pigs
279. Anti inflammatory activity of salmeterol: Down-regulation of cytokine production
280. cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization
281. An interleukin-l-beta-induced noradrenaline release in the spleen is mediated by brain corticotropin-releasing factor: An in vivo microdialysis study in conscious rats
282. Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex
283. Cyclic adenosine 3′,5′-monophosphate in human lymphocytes. Alterations after phytohemagglutin in stimulation
284. Human lymphocyte metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin
285. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes
286. Correlation of plasma catecholamine levels with hemodynamic changes in canine endotoxin shock
287. Beta-adrenergic receptors and adenylate cyclase activity in murine lymphoid cell lines
288. 2, immune complexes, and IFN-gamma
289. Dialogue between the CNS and the immune system in lymphoid organs
290. Structure and function of the beta 3-adrenergic receptor
291. Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand. Involvement of transcriptional and posttranscriptional mechanisms
292. IFN-gamma production by Th1 cells generated from naive CD4(+) T cells exposed to norepinephrine
293. Th1/Th2 subsets: Distinct differences in homing and chemokine receptor expression?
294. Effects of interleukin-1 beta on blood pressure, sympathetic nerve activity, and pituitary endocrine functions in anesthetized rats
295. Dynamic norepinephrine alterations in bone marrow: Evidence of functional innervation
296. Histone H4 acetylation during interleukin-2 stimulation of mouse T cells
297. Biphasic effect of cyclic AMP on an immune response
298. Differential effect of the activation of protein kinase A on the protein synthesis and secretion in the T-helper 2 cell line D10.G4.1
299. Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP
300. The innervation of the spleen
301. Low beta-adrenergic receptor concentration on human thymocytes
302. Interleukin (IL)-4 production by human T cells: Differential regulation of IL-4 vs IL-2 production
303. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production
304. Anterior hypothalamic lesions prevent the endotoxin-induced reduction of beta-adrenoceptor number in the guinea pig lung
305. Catecholamines increase lymphocyte beta-2-adrenergic receptors via a beta-2-adrenergic, spleen-dependent process
306. Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6
307. Modulation of IL-2- and IL-4-dependent human B cell proliferation by cyclic AMP
308. Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes
309. Differential induction of c-Fos immunoreactivity in hypothalamus and brain stem nuclei following central and peripheral administration of endotoxin
310. Neural and biochemical mediators of endotoxin and stress-induced c-fos expression in the rat brain
311. The influence of intracellular levels of cyclic nucleotides on cell proliferation and the induction of antibody synthesis
312. Cyclic nucleotides as intracellular mediators of the expression of antigen-sensitive cells
313. Effects of taste aversion conditioning on the primary antibody response to sheep red blood cells and Brucella abortus in the albino rat
314. Lymphocyte targeting of the central nervous system: A review of afferent and efferent CNS-immune pathways
315. Down-regulation of glucocorticoid and beta-adrenergic receptors on lectin-stimulated splenocytes
316. Sympathetic innervation of murine thymus and spleen: A comparative histofluorescence study
317. Sympathetic innervation of murine thymus and spleen: Evidence for a functional link between the nervous and immune systems
318. 3H -alprenolol binding
319. Regulation of CD40L expression by cyclic AMP: Contrasting proinflammatory and inhibitory actions
320. Cyclic adenosine monophosphate (cAMP) differentially regulates IL-4 in thymocyte subsets
321. In vitro study of beta-adrenergic receptors
322. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor
323. Plasticity of GAP-43 innervation of the spleen during immune response in the mouse. Evidence for axonal sprouting and redistribution of the nerve fibers
324. Interleukin-2-induced enhancement of an antigen-specific IgM plaque-forming cell response is mediated by the sympathetic nervous system
325. Changes in tissue content of catechol amines in traumatic shock
326. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation